The High Cost Drugs Subgroups (HCDSG) were previously responsible for the development and update of pathways and commissioning statements relating to specified high cost drugs (i.e., PbR-excluded drugs). At certain points these functions were split between the High Cost Drugs Operational Group (HCDOG) and High Cost Drugs Strategic Group (HCDStG).

Minutes from meetings of these groups are available below.

Document Title Issue Date Review Date Status
HCDSG minutes August 2020 20200902 Sep 2020 Approved
HCDSG minutes June 2020 20200802 Aug 2020 Approved
HCDSG minutes February 2020 20200802 Aug 2020 Approved
HCD Strategic Group minutes November 2019 20200202 Feb 2020 Approved
HCD Operational Group minutes November 2019 20200202 Feb 2020 Approved
HCD Operational Group minutes October 2019 20191102 Nov 2019 Approved
HCD Strategic Group minutes September 2019 20191102 Nov 2019 Approved
HCD Operational Group minutes September 2019 20191002 Oct 2019 Approved
HCD Operational Group minutes August 2019 20190902 Sep 2019 Approved
HCD Operational Group minutes July 2019 20190802 Aug 2019 Approved
HCDSG minutes June 2019 20190702 Jul 2019 Approved
HCDSG minutes April 2019 20190602 Jun 2019 Approved
HCDSG minutes March 2019 20190402 Apr 2019 Approved
HCDSG minutes February 2019 20190302 Mar 2019 Approved
HCDSG minutes October 2018 20190202 Feb 2019 Approved
HCDSG minutes September 2018 20181002 Oct 2018 Approved
HCDSG minutes August 2018 20180902 Sep 2018 Approved
HCDSG minutes June 2018 20180802 Aug 2018 Approved
HCDSG minutes May 2018 20210602 Jun 2021 Approved
HCDSG minutes April 2018 20180502 May 2018 Approved
HCDSG minutes March 2018 20180402 Apr 2018 Approved
HCDSG minutes January 2018 20180302 Mar 2018 Approved